Institutional investors hold a majority ownership of AGN through the 93.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended September 2015, these large investors purchased a net $16.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PENTWATER CAPITAL MANAGEMENT LP Bought 4.1 Million shares of Allergan
JANUS CAPITAL MANAGEMENT LLC Bought 2.2 Million shares of Allergan
T. ROWE PRICE ASSOCIATES, INC. Bought 1.6 Million shares of Allergan